Author

A. Chattopadhyay Pal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

C. Ben Mamoun· 2 shared I. Renard· 2 shared P. Vydyam· 2 shared A. Bei· 1 shared A. Garcia-Perez· 1 shared A. Nilsen· 1 shared A. Saraf· 1 shared B. Almassian· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. Ben Mamoun

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintNov 21, 2023

A Potent Kalihinol Analogue Disrupts Apicoplast Function and Vesicular Trafficking in P. falciparum Malaria.

Z. M. Chahine, S. Abel, T. Hollin…·K. G. Le Roch

This paper identifies MED6-189, a potent antimalarial compound that disrupts apicoplast function and vesicular trafficking in P. falciparum, showing efficacy against drug-resistant strains and demonstrating a unique mechanism of action.

DOI 10.1101/2023.11.21.568162

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivMar 31, 2021

Effective Therapy Targeting Cytochrome bc1 Prevents Babesia Erythrocytic Development and Protects from Lethal Infection

J. E. Chiu, I. Renard, A. Chattopadhyay Pal…·C. Ben Mamoun

This study identifies an effective ELQ prodrug that prevents Babesia erythrocytic development and protects against lethal infection in mouse models.

DOI 10.1128/aac.00662-21

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivFeb 19, 2019

Virus-like vesicles expressing multiple antigens for immunotherapy of chronic hepatitis B

T. O. Yarovinsky, S. W. Mason, M. Menon…·V. Nakaar

This paper develops virus-like vesicles (VLV) expressing multiple HBV antigens for immunotherapy of chronic hepatitis B, showing 40% efficacy in a mouse model.

DOI 10.1016/j.isci.2019.10.040

mouseexperimental assay

𝕏 PostBluesky